Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor Phase 2b in IBS-C
NCT01923428Phase 3Completed
- Sponsor
- Ardelyx
- Start
- Aug 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in irritable bowel syndrome (IBS), sponsored by Ardelyx. Started Aug 2013; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01923428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923428.